Healthy adults
Conditions
Interventions
Study food will be ingested once daily, for 8 weeks.
Placebo will be ingested once daily, for 8 weeks.
Sponsors
IMEQRD Co., Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Age between 30 and 59 years at the time of informed consent 2.Japanese male or female 3.Those who have neck stiffness 4.Those who consider themselves feeling of cold 5.BMI of over 18.5 to under 25.0 6.Those who are able to input electronic diary with smartphone / PC 7.Those who received sufficient explanation about the trial, volunteered to participate after understanding the purpose, and agree to participate in the trial with written consent
Exclusion criteria
Exclusion criteria: 1.Those who has been currently visiting a hospital or treated with any drug or herbal remedy (however, dosing as needed is allowed) for any disease 2.On diet / exercise therapy under the guidance of a doctor 3.Have a current or history of serious illness 4.Those who have heavy anemia 5.Those who are currently taking drugs, quasi-drug products, foods, or supplements which have health claim for improvement of fatigue, stress, cold sensitivity, blood flow, blood pressure 6.Those who are currently employing devices for improvement of fatigue, stress, cold sensitivity, blood flow, blood pressure (such as massage devices, elastic stockings, and low-frequency electric therapy devices). (except for those who can discontinue using such devices during the trial period after obtaining informed consent) 7.Those who have a cold allergy, a drug allergy, or a food allergy. Those who experienced those allergy symptoms. 8.Smokers (who have not been smoking for the last year) 9.Excessive consumption of alcohol (alcohol equivalent 60g or more / day) 10.Those who have menstrual irregularity. 11.Those who donated blood (including plasma or serum) more than 400 mL (men) within three months before obtaining informed consent. 12.Those who donated blood (including plasma or serum) more than 200 mL (women) within three months before obtaining informed consent. 13.Planning to significantly change their lifestyle (diet, sleep, exercise, etc.) during the trial 14.Irregular diet, shift worker, night shift, irregular life rhythm 15.Those who are planning travels to foreign countries during the trial period. 16.Those who are currently pregnant or breastfeeding or those who want to become pregnant during the test period 17.Participation in another clinical trial within one month of enrollment into the trial, participating currently or planning to participate 18.Those who were determined by the investigator to be unsuitable for participation in this clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body surface temperature | — |
Secondary
| Measure | Time frame |
|---|---|
| Body temperature Blood flow Questionnaire for subjective evaluation | — |
Countries
Japan
Contacts
Public ContactHirokuni Kayama
IMEQRD Co., Ltd Planning and Sales Department
Outcome results
None listed